Janet L. Anderl
About
Janet L. Anderl has authored 27 papers that have received a total of 906 indexed citations.
This includes 21 papers in Molecular Biology, 10 papers in Hematology and 9 papers in Oncology. The topics of these papers are Ubiquitin and proteasome pathways (16 papers), Peptidase Inhibition and Analysis (9 papers) and Multiple Myeloma Research and Treatments (9 papers). Janet L. Anderl is often cited by papers focused on Ubiquitin and proteasome pathways (16 papers), Peptidase Inhibition and Analysis (9 papers) and Multiple Myeloma Research and Treatments (9 papers) and collaborates with scholars based in United States, The Netherlands and Israel. Janet L. Anderl's co-authors include Christopher J. Kirk, Tony Muchamuel, Yehuda G. Assaraf, Henry W. B. Johnson and Jacqueline Cloos and has published in prestigious journals such as Blood, Clinical Cancer Research and Journal of Medicinal Chemistry.
In The Last Decade
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by Michael Nocker Breakdown of academic impact, for papers by Christopher Krupenye Breakdown of academic impact, for papers by Nynne Nyboe Andersen Breakdown of academic impact, for papers by Sulabha Ramachandran Breakdown of academic impact, for papers by Bruce Culver Breakdown of academic impact, for papers by R. F. Kruh Breakdown of academic impact, for papers by August G. Domel Breakdown of academic impact, for papers by Paul Collier